These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3362892)

  • 1. The results of treatment of 1,475 patients with bladder carcinoma in the region of Amsterdam, The Netherlands.
    Rasker FM
    Prog Clin Biol Res; 1988; 260():347-56. PubMed ID: 3362892
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined radiosurgical treatment of bladder carcinoma: preliminary results of a prospective trial.
    Salvi G; Balducci M; Cellini N; D'Andrea P; De Santis M; Valentini V; Romanini A
    Rays; 1985; 10(3):133-9. PubMed ID: 3843662
    [No Abstract]   [Full Text] [Related]  

  • 3. Superficial TCC bladder cancer: the impact of tumor differentiation on recurrence, progression and survival.
    Kurth KH
    Prog Clin Biol Res; 1984; 162A():307-18. PubMed ID: 6483914
    [No Abstract]   [Full Text] [Related]  

  • 4. Radical radiotherapy and salvage cystectomy for T2/3 cancer of the bladder.
    Blandy JP; Jenkins BJ; Fowler CG; Caulfield M; Badenoch DF; England HR; Hope-Stone HF; Mair GM; Mantell BS; Oliver RT
    Prog Clin Biol Res; 1988; 260():447-51. PubMed ID: 3129734
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined radiotherapy, chemotherapy and surgery in the management of invasive bladder cancer.
    Jakse G; Frommhold H
    Prog Clin Biol Res; 1988; 269():591-600. PubMed ID: 3393556
    [No Abstract]   [Full Text] [Related]  

  • 6. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 64 patients.
    Montie JE
    J Urol; 2005 Jun; 173(6):1920-1. PubMed ID: 15879778
    [No Abstract]   [Full Text] [Related]  

  • 7. Neoadjuvant intravenous cisplatin for T2-4NxMo bladder cancer.
    Raghavan D; Pearson B; Duval P; Rogers J; Watt H; Tynan A
    Prog Clin Biol Res; 1988; 260():561-70. PubMed ID: 3362905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of the therapy of papillary bladder tumors. I. The therapeutic effect of the surgical treatment procedure in combination with radiotherapy].
    Kob D; Arndt J; Albert L; Herrmann S; Kriester A
    Radiobiol Radiother (Berl); 1979 Aug; 20(4):493-8. PubMed ID: 523611
    [No Abstract]   [Full Text] [Related]  

  • 9. The management and outcome of bladder carcinoma in Ontario, 1982-1994.
    Hayter CR; Paszat LF; Groome PA; Schulze K; Mackillop WJ
    Cancer; 2000 Jul; 89(1):142-51. PubMed ID: 10897011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer: clinical practice.
    Rabinowits G; Laber DA
    J Ky Med Assoc; 2009 Apr; 107(4):129-33. PubMed ID: 19419018
    [No Abstract]   [Full Text] [Related]  

  • 11. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standards and perspectives in diagnosis and therapy of bladder carcinoma].
    Stief C; Zaak D; Stöckle M; Studer U; Knuechel R; Rödel C; Sauer R; Rubben H
    Urologe A; 2006 Sep; 45 Suppl 4():90-6. PubMed ID: 16896761
    [No Abstract]   [Full Text] [Related]  

  • 13. Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
    Zietman AL; Shipley WU; Kaufman DS; Esrig D; Lytton B
    Contemp Urol; 1995 Jul; 7(7):23-4, 29, 32, passim. PubMed ID: 10150577
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.
    Kachnic LA; Shipley WU; Griffin PP; Zietman AL; Kaufman DS; Althausen AF; Heney NM
    Cancer J Sci Am; 1996; 2(2):79-84. PubMed ID: 9166504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
    Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
    BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
    Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder carcinoma treated by irradiation and surgery: interval report.
    Deweerd JH; Colby MY
    Trans Am Assoc Genitourin Surg; 1972; 64():74-8. PubMed ID: 4654525
    [No Abstract]   [Full Text] [Related]  

  • 20. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT; Soloway MS
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.